Novel drug shows promising efficacy for patients with multiple myeloma

Results of an international clinical trial co-led by researchers at Winship Cancer Institute at Emory University show potential for a novel drug to benefit patients with multiple myeloma whose disease either recurred or was resistant to three or more earlier lines of treatment.

source https://medicalxpress.com/news/2022-08-drug-efficacy-patients-multiple-myeloma.html